Latest Adenocarcinoma Stories
MANHATTAN BEACH, Calif., May 6, 2011 /PRNewswire/ -- Yesterday, the U.S. Food and Drug Administration (FDA) approved the Novartis drug AfinitorÂ® (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors.
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.
Heavy drinking is not associated with one of the two most common types of gullet (oesophageal) cancer, according to this study.
Heavy drinking is not associated with one of the two most common types of gullet (oesophageal) cancer, suggests research published online in Gut.
Lung cancer is considered the 6th most common cause of cancer deaths in the United States.
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
SEATTLE, Feb. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.
John Hopkins University researchers said on Thursday that they have discovered the reason some people are able live for years with the same kind of rare pancreatic cancer that has inflicted people like Apple's CEO Steve Jobs.
WALTHAM, Mass., Jan.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.